Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1951 1
1952 1
1953 1
1954 1
1967 1
1978 1
1981 3
1987 1
1988 1
1992 1
1993 3
1995 1
1996 1
2002 1
2003 1
2004 3
2005 2
2006 6
2007 11
2008 2
2009 4
2010 5
2011 6
2012 7
2013 4
2014 6
2015 6
2016 3
2017 4
2018 1
2019 3
2020 1
2021 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Polman CH, et al. Among authors: phillips jt. N Engl J Med. 2006 Mar 2;354(9):899-910. doi: 10.1056/NEJMoa044397. N Engl J Med. 2006. PMID: 16510744 Free article. Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. Among authors: phillips jt. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Free article. Clinical Trial.
BG-12 in multiple sclerosis.
Phillips JT, Fox RJ. Phillips JT, et al. Semin Neurol. 2013 Feb;33(1):56-65. doi: 10.1055/s-0033-1343796. Epub 2013 May 25. Semin Neurol. 2013. PMID: 23709213 Review.
Polypharmacy in multiple sclerosis.
Myers LW, Phillips JT. Myers LW, et al. Among authors: phillips jt. Epilepsy Res Suppl. 1996;11:181-95. Epilepsy Res Suppl. 1996. PMID: 9294736 Review.
Translational research in neurology and neuroscience 2010: multiple sclerosis.
Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, Khan O, Eagar TN. Stüve O, et al. Among authors: phillips jt. Arch Neurol. 2010 Nov;67(11):1307-15. doi: 10.1001/archneurol.2010.158. Epub 2010 Jul 12. Arch Neurol. 2010. PMID: 20625066 Free PMC article. Review.
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
Fox RJ, Kita M, Cohan SL, Henson LJ, Zambrano J, Scannevin RH, O'Gorman J, Novas M, Dawson KT, Phillips JT. Fox RJ, et al. Among authors: phillips jt. Curr Med Res Opin. 2014 Feb;30(2):251-62. doi: 10.1185/03007995.2013.849236. Epub 2013 Oct 22. Curr Med Res Opin. 2014. PMID: 24131282 Review.
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. Frohman EM, et al. Among authors: phillips jt. Arch Neurol. 2005 Oct;62(10):1519-30. doi: 10.1001/archneur.62.10.1519. Arch Neurol. 2005. PMID: 16216934 Review.
88 results